Tag: Zodasiran

Low circulating cholesterol in neonates linked with pyloric stenosis

ANGPLT3 interfering RNA therapy reduces triglyceride levels in mixed hyperlipidemia

byNhat Hung (Benjamin) Lamand1 others

October 14, 2024

1. Zodasiran, an RNA interference (RNAi) therapy targeting angiopoietin-like 3 (ANGPTL3), resulted in a dose-dependent reduction in ANGPTL3 and triglyceride ...

PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study

Zodasiran associated with reduced triglyceride levels among adults with mixed hyperlipidemia

byThomas Suand1 others

June 11, 2024

1. In this randomized controlled trial, adults with mixed hyperlipidemia who received zodasiran had dose-dependent decreases in triglyceride levels compared ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: Zodasiran

ANGPLT3 interfering RNA therapy reduces triglyceride levels in mixed hyperlipidemia

Zodasiran associated with reduced triglyceride levels among adults with mixed hyperlipidemia

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits